TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Mono- or Dual Combination Oral Antihyperglycemic Therapy


Awarded By

Total Award Amount

  • 304735.00
  • Direct Costs

  • 241855.00
  • Sponsor Award Id

  • 082
  • Contributor

  • W. Timothy Garvey   Principal Investigator